Robert F. Kennedy Jr. testifies in confirmation hearings before the Senate’s Finance Committee on Wednesday, and will appear Thursday before the health committee.

The National Institutes of Health funds research, but some scientists fear that funding may be pulled or paused by the Trump administration.

Robert F. Kennedy Jr. is set to appear before the Senate’s finance committee, in the first of two days of hearings before senators vote on whether to confirm him as President Trump’s health secretary.

Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the National Institutes of Health

The UT System is "closely monitoring" the federal funding situation. President Trump also signed orders lifting restrictions on arresting students.

If he is confirmed as Health and Human Services secretary, Robert F. Kennedy Jr. would take over a sprawling bureaucracy with an annual budget that tops $1.7 trillion, with more than 80,000 employees and 13 divisions.

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded. Scientists worry about disruptions to critical research.

U.S. states have been under siege for the past five days with a flurry of executive orders aimed at dismantling national health. Medicaid payments are frozen, leaving the one in four North Carolina residents who access this program without care.

The director of the National Institutes of Health, Dr. Monica Bertagnolli, announced that she will step down Friday, 14 months after she took the position on Nov. 9, 2023.

Data: National Science Foundation and National Institutes of Health; Map: Alex Fitzpatrick/Axios Some states have far more to lose than others if the second Trump administration cuts federal health and science funding.

A local UT Health San Antonio doctor has been appointed to the Health and Human Services Advisory Committee on Long COVID.

At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has focused on influenza and respiratory viruses with regard to vaccines, transmission, and at-risk populations.